Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Verhoeven

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Neurobiology of Aging|January 21, 2014
Dysregulated physiological stress systems and accelerated cellular agingDóra Révész, Josine E Verhoeven, Yuri Milaneschi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 15, 2006
Layer-by-layer coating of degradable microgels for pulsed drug deliveryB G De Geest, C Déjugnat, E Verhoeven, et al.
BMC Medicine|December 13, 2017
Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the ruleJudith Verduijn, Josine E Verhoeven, Yuri Milaneschi, et al.
Molecular Psychiatry|March 29, 2017
Depression, telomeres and mitochondrial DNA: between- and within-person associations from a 10-year longitudinal studyJ E Verhoeven, D Révész, M Picard, et al.
Journal of Chromatographic Science|November 15, 2008
Evaluation of orthogonal/dissimilar RP-HPLC systems sets for their suitability as method-development starting points for drug impurity profilesE Van Gyseghem, E Deconinck, M Dumarey, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 25, 2009
Modeling drug release from hot-melt extruded mini-matrices with constant and non-constant diffusivitiesE Verhoeven, F Siepmann, T R M De Beer, et al.
Drug Discovery Today|July 14, 2015
Telomerase activation as a possible mechanism of action for psychopharmacological interventionsFrancesco S Bersani, Daniel Lindqvist, Synthia H Mellon, et al.
Cell Adhesion and Communication|November 21, 1998
Characterization of the EMS1 gene and its product, human CortactinE Schuuring, H van Damme, E Schuuring-Scholtes, et al.
Psychosomatic Medicine|July 1, 2016
The Association Between Psychiatric Disorders and Telomere Length: A Meta-Analysis Involving 14,827 PersonsSabrina M Darrow, Josine E Verhoeven, Dóra Révész, et al.
Brain, Behavior, and Immunity|October 30, 2024
Running therapy or antidepressants as treatments for immunometabolic depression in patients with depressive and anxiety disorders: A secondary analysis of the MOTAR studySarah R Vreijling, Brenda W J H Penninx, Josine E Verhoeven, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Neurobiology of Aging|January 21, 2014
Dysregulated physiological stress systems and accelerated cellular agingDóra Révész, Josine E Verhoeven, Yuri Milaneschi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 15, 2006
Layer-by-layer coating of degradable microgels for pulsed drug deliveryB G De Geest, C Déjugnat, E Verhoeven, et al.
BMC Medicine|December 13, 2017
Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the ruleJudith Verduijn, Josine E Verhoeven, Yuri Milaneschi, et al.
Molecular Psychiatry|March 29, 2017
Depression, telomeres and mitochondrial DNA: between- and within-person associations from a 10-year longitudinal studyJ E Verhoeven, D Révész, M Picard, et al.
Journal of Chromatographic Science|November 15, 2008
Evaluation of orthogonal/dissimilar RP-HPLC systems sets for their suitability as method-development starting points for drug impurity profilesE Van Gyseghem, E Deconinck, M Dumarey, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 25, 2009
Modeling drug release from hot-melt extruded mini-matrices with constant and non-constant diffusivitiesE Verhoeven, F Siepmann, T R M De Beer, et al.
Drug Discovery Today|July 14, 2015
Telomerase activation as a possible mechanism of action for psychopharmacological interventionsFrancesco S Bersani, Daniel Lindqvist, Synthia H Mellon, et al.
Cell Adhesion and Communication|November 21, 1998
Characterization of the EMS1 gene and its product, human CortactinE Schuuring, H van Damme, E Schuuring-Scholtes, et al.
Psychosomatic Medicine|July 1, 2016
The Association Between Psychiatric Disorders and Telomere Length: A Meta-Analysis Involving 14,827 PersonsSabrina M Darrow, Josine E Verhoeven, Dóra Révész, et al.
Brain, Behavior, and Immunity|October 30, 2024
Running therapy or antidepressants as treatments for immunometabolic depression in patients with depressive and anxiety disorders: A secondary analysis of the MOTAR studySarah R Vreijling, Brenda W J H Penninx, Josine E Verhoeven, et al.
Pageof 10